Cargando...
A RARE CAUSE OF PITUITARY APOPLEXY: CABERGOLINE THERAPY
Pituitary apoplexy (PA) is a life-threatening clinical syndrome. Dopamine receptor agonists are the drugs of choice in the treatment of prolactinomas. The use of cabergoline is reported to cause an increased risk of PA, particularly in macroprolactinomas of cystic nature. In this report, we present...
Gardado en:
| Publicado en: | Acta Endocrinol (Buchar) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Acta Endocrinologica Foundation
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516607/ https://ncbi.nlm.nih.gov/pubmed/31149244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4183/aeb.2018.113 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|